RIYADH, Saudi Arabia, May 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has achieved a significant milestone by winning the 2024 Tech Impact Award, a prestigious recognition presented by the ...
Read MoreMay 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. This ratio was based ...
Read MoreMount Elizabeth Novena Hospital (MNH) Singapore is the first private hospital in the region to offer proton therapy; kicked off treatment for first patient on 10 May 2023. Centre has already treated more than 100 patients from 16 countries, ...
Read More[Minneapolis, Minnesota, Chanhassen], May 14, 2024 (GLOBE NEWSWIRE) -- MedSource Labs moves the needle in the peripheral safety IV market with the announcement of ClearSafe Comfort and TrueSafe Comfort Blood Control IV Catheters with ...
Read MoreBURLINGAME, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”), a nonprofit industry association enhancing data exchange for the life sciences-regulatory industry, is proud to share a newly published global standard ...
Read MoreRIYADH, Saudi Arabia, May 13, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) has recently welcomed Dr. Björn Zoéga as its Deputy CEO, an appointment that underscores its commitment to promoting and ...
Read MoreMerger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology Combined company is expected to have approximately $120 million of cash resources at ...
Read MoreOrgan donation and transplant program gaining momentum in Pune with increased awareness and confidence amongst people – Dr. Bipin Vibhute PUNE, India , Jan. 13, 2022 /PRNewswire/ -- With increased awareness and confidence amongst common ...
Read More----Previous clinical trials demonstrated ASC40 is safe and inhibits human facial sebum production in a dose-dependent fashion HANGZHOU and SHAOXING, China , Jan. 13, 2022 /PRNewswire/ --Â Ascletis Pharma Inc. (HKEX: 1672) today announces ...
Read MoreThe study adds important new knowledge to the evolving field of transgender health care BOSTON , Jan. 12, 2022 /PRNewswire-PRWeb/ --Â A study published in PLOS One found that access to gender-affirming hormones during adolescence is ...
Read MoreTeam PHenomenal Hope reopens its research fund. BELOIT, Wis. , Jan. 12, 2022 /PRNewswire-PRWeb/ --Â Team PHenomenal Hope (Team PH), a nonprofit organization, has announced the reopening of their research fund, the PHenomenal Impact Fund for ...
Read MoreOTTAWA, ON , Jan. 12, 2022 /CNW/ - Summary Product: Â Xeljanz and Xeljanz XR (tofacitinib), a prescription drug used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Issue: Â Health Canada's safety review found a link ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers